Analyst Ratings for Atara Biotherapeutics (ATRA) [Neutrals]
ATRA Rating Summary
ATRA Price Target Summary
- Highest: $13.00 (Canaccord Genuity)
- Lowest: $0.50 (Goldman Sachs)
- Average: $4.20
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$4.20 (+491.5%)
* Over Last 12-Mos
Rating Score: 3.3 / 10 Percentile Rank: 30%
Rating Score: 3.3 / 10 Percentile Rank: 30%
Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|---|
11/9/2023 | Evercore ISI | Johnathan Miller | Downgrade | In Line (Outperform) |
N/A (N/A) |
1.21 (0.71) |
-41.32% | Details |
11/9/2023 | H.C. Wainwright | Robert Burns | Downgrade | Neutral (Buy) |
N/A (N/A) |
1.21 (0.71) |
-41.32% | Details |